RAIDEN RESOURCES LIMITED — Capital/Financing Update 2006

Jun 29, 2006

Company Update

MEDICAL MONITORS LIMITED

30 June 2006

MDM to Reduce Debt

Medical Monitors Limited (ASX:MDM) is pleased to announce its intention to convert current and non-current debt into equity, subject to shareholder approval at a general meeting (EGM). The date for the EGM will be confirmed next month.

Approval will be sort for the issue of up to 6 million ordinary shares to be made at $0.22, and up to 6 million unlisted options (payable at 20 cents, with expiry date 30 June 2008) as part of the transaction.

The transaction will potentially extinguish up to 80% of current and non-current liabilities, specifically being applied to loans provided to the Company by Directors, Officers and consultants over the past three years.

About Medical Monitors:

Medical Monitors (ASX: MDM) specialises in home-based medical monitoring technology. The Company's unique transtelephonic (telephone transfer) technologies, allowing doctors to remotely monitor the cardiovascular health of heir patients, have been granted US Food and Drug Administration (FDA) notification to enable marketing and sales.

The US arrhythmia monitoring market estimated to be more that USD$550 million per annum. Medical Monitors technology is distributed in the US through Primedical International Inc., and its subsidiary company iCardia Healthcare Corporation, with further expansion of its distribution network into Europe and the UK.

For further information, please contact Dr Allan Shell on (02) 9344 8100.

Medical Monitors Limit Suite 407 Westfield Eastgarde Eastgardens NSW 20 Tel (02) 9344 8100 Fax (02) 9344 82 Web site: www.medmon.com.